• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fulcrum Therapeutics Inc (NQ: FULC )

    3.210 +0.050 (+1.58%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Fulcrum Therapeutics Inc

    < Previous 1 2 3 4 5 6 Next >
    Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
    The company is working on treatments for forms of muscular dystrophy, and is taking on some of the biggest names in pharma. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
    Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. 
    Via Investor's Business Daily
    Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14
    What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 9-13, 2024. 
    Via Talk Markets
    Breaking Down Fulcrum Therapeutics: 7 Analysts Share Their Views
    Via Benzinga
    Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
    Via Benzinga
    Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
    Via Benzinga
    Dow Surges Over 100 Points; ModivCare Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
    Fulcrum Therapeutics stock drops after Phase 3 REACH trial of losmapimod flops in Facioscapulohumeral Muscular Dystrophy. The company consider suspending the program. 
    Via Benzinga
    US Stocks Mixed; Producer Prices Increase In August
    Via Benzinga
    Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
    BofA Securities upgraded Fulcrum Therapeutics ahead of its phase 3 losmapimod results for Facioscapulohumeral muscular dystrophy, boosting the price target from $5 to $10 due to increased confidence in... 
    Via Benzinga
    Earnings Preview: Fulcrum Therapeutics
    Via Benzinga
    Preview: Fulcrum Therapeutics's Earnings
    Via Benzinga
    The Latest Analyst Ratings for Fulcrum Therapeutics
    Via Benzinga
    8 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    FULC Stock Earnings: Fulcrum Therapeutics Beats EPS for Q1 2024
    FULC stock results show that Fulcrum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
    Via InvestorPlace
    Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
    With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks. 
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. 
    Via Benzinga
    MicroMarvet - Fulcrum Therapeutics - Confusing Projections And Recommendation
    Revenue is estimated to be down 63.40% this year and down another 19.80% next year. Earnings are projected to increase 32.80% this year but be down 9.80% next year. 
    Via Talk Markets
    Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
    Via Benzinga
    Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. 
    Via Benzinga
    Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers Electriq Power Holdings, Inc. (NYSE: ELIQ) shares jumped 130.3% to $3.3847. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.